Blue Bell Private Wealth Management’s Novartis NVS Stock Holding History
Bought
Maintained
Sold
Other funds holding NVS
Blue Bell Private Wealth Management's NVS Position: Q3 2022 in Review
Blue Bell Private Wealth Management sold out of Novartis (NVS) in Q3 2022, closing a stake of 431 shares — an estimated $36K sold.
Blue Bell Private Wealth Management first reported a position in NVS in Q4 2021 and held it in 3 quarters. The position peaked at $38K in Q1 2022. 1,088 funds tracked by Wall St. Rank hold NVS as of Q3 2022.
- Blue Bell Private Wealth Management reported no remaining Novartis position as of Q3 2022 after selling out during the quarter.
- Blue Bell Private Wealth Management sold 431 Novartis shares in Q3 2022, an estimated $36K.
- Blue Bell Private Wealth Management first reported a position in Novartis in Q4 2021 and held it in 3 quarters.
- Blue Bell Private Wealth Management's Novartis position peaked at $38K in Q1 2022.
- 1,088 funds tracked by Wall St. Rank held Novartis as of Q3 2022.
Based on Blue Bell Private Wealth Management's 13F filing for Q3 2022, filed 9 Nov 2022.